Toh Uhi相关文献与解析，生知库 | 链接生命科学的每一步

Fujiyoshi Kenji, Sugihara Rie, Miyamoto Naoki, Watanabe Yoriko, Sudo Tomoya, Numata Sanae, Akiba Jun, Abe Hideyuki, Ichinose Yuka, Inoue Kenji, Ozono Shuichi, Ono Takeharu, Orioka Kentaro, Kashihara Masaki, Kajiwara Ryousuke, Kawano Hiroyuki, Kawahara Akihiko, Takase Ryuta, Toh Uhi, Hashimoto Kazuaki, Hisaka Toru, Hirai Shingo, Mitsuoka Masahiro, Miyazaki Daiki, Yoshitomi Fumi, Yamamoto Ken, Umeno Hirohito, Nomura Masahisa, Naito Yoshiki

肿瘤

肿瘤免疫

发表日期：2025

文献求助收藏

Axillary surgery in patients with breast cancer with one to three positive micro- or macrometastases in the sentinel lymph nodes: an observational study

腋窝手术治疗前哨淋巴结中存在 1 至 3 个微转移或大转移的乳腺癌患者：一项观察性研究

期刊:Breast Cancer

影响因子:2.9

doi:10.1007/s12282-025-01726-2

Imoto, Shigeru; Yasojima, Hiroyuki; Nagashima, Takeshi; Onishi, Tatsuya; Takashima, Tsutomu; Kitada, Masahiro; Kawada, Masaya; Hayashida, Tetsu; Naoi, Yasuto; Aihara, Tomohiko; Wada, Noriaki; Kawabata, Hidetaka; Yoshida, Masayuki; Toh, Uhi; Yoneyama, Kimiyasu; Yamada, Akimitsu; Tsuda, Hitoshi; Masuda, Norikazu; Saito-Oba, Mari; Sakamoto, Junichi

Male Occult Primary Breast Cancer Diagnosed with Small Bowel Metastases: A Case Report

男性隐匿性原发性乳腺癌伴小肠转移：病例报告

期刊:Surgical Case Reports

影响因子:0.7

doi:10.70352/scrj.cr.24-0089

Ogata, Suguru; Toh, Uhi; Ozaki, Kunihiro; Mihara, Yutaro; Ogata, Nanae; Takao, Yuko; Saku, Shuko; Sugihara, Rie; Fujita, Fumihiko

The effective duration of systemic therapy and the neutrophil-to-lymphocyte ratio predict the surgical advantage of primary tumor resection in patients with de novo stage IV breast cancer: a retrospective study

系统治疗的有效持续时间和中性粒细胞与淋巴细胞比值可预测初诊IV期乳腺癌患者原发肿瘤切除术的手术优势：一项回顾性研究

期刊:World Journal of Surgical Oncology

影响因子:2.5

doi:10.1186/s12957-024-03586-0

Sugihara, Rie; Watanabe, Hidetaka; Matsushima, Shuntaro; Katagiri, Yuriko; Saku, Shuko; Okabe, Mina; Takao, Yuko; Iwakuma, Nobutaka; Ogo, Etsuyo; Fujita, Fumihiko; Toh, Uhi

Fulvestrant plus palbociclib in advanced or metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer after fulvestrant monotherapy: Japan Breast Cancer Research Group-M07 (FUTURE trial)

在接受氟维司群单药治疗后，晚期或转移性激素受体阳性/人表皮生长因子受体 2 阴性乳腺癌患者接受氟维司群联合帕博西尼治疗的疗效：日本乳腺癌研究组-M07（FUTURE 试验）

期刊:Breast Cancer Research and Treatment

影响因子:3

doi:10.1007/s10549-023-06911-5

Watanabe, Kenichi; Niikura, Naoki; Kikawa, Yuichiro; Oba, Mari; Kobayashi, Kokoro; Tada, Hiroshi; Ozaki, Shinji; Toh, Uhi; Yamamoto, Yutaka; Tsuneizumi, Michiko; Okuno, Toshitaka; Iwakuma, Nobutaka; Takeshita, Takashi; Iwamoto, Takayuki; Ishiguro, Hiroshi; Masuda, Norikazu; Saji, Shigehira

Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study

贝伐珠单抗联合紫杉醇作为局部晚期或转移性乳腺癌一线或二线化疗的前瞻性观察研究：JBCRG-C05 (B-SHARE) 研究

期刊:Breast Cancer

影响因子:2.9

doi:10.1007/s12282-020-01138-4

Yamamoto, Yutaka; Yamashiro, Hiroyasu; Toh, Uhi; Kondo, Naoto; Nakamura, Rikiya; Kashiwaba, Masahiro; Takahashi, Masato; Tsugawa, Koichiro; Ishikawa, Takashi; Nakayama, Takahiro; Ohtani, Shoichiro; Takano, Toshimi; Fujisawa, Tomomi; Toyama, Tatsuya; Kawaguchi, Hidetoshi; Mashino, Kojiro; Tanino, Yuichi; Morita, Satoshi; Toi, Masakazu; Ohno, Shinji

Clinical outcomes of patients after nipple-sparing mastectomy and reconstruction based on the expander/implant technique

保留乳头乳房切除术和基于扩张器/假体技术的重建术后患者的临床结果

期刊:Surgery Today

影响因子:1.6

doi:10.1007/s00595-020-02175-4

Toh, Uhi; Takenaka, Miki; Iwakuma, Nobutaka; Akagi, Yoshito

发表日期：2021

文献求助收藏

Plasma level of prostate related-antigen peptide-reactive IgG is a prognostic factor of patients with breast cancer treated with personalized peptide vaccines

血浆中前列腺相关抗原肽反应性IgG水平是接受个性化肽疫苗治疗的乳腺癌患者的预后因素。

期刊:

影响因子:

doi:10.3892/etm.2021.10337

Saku, Shuko; Toh, Uhi; Takao, Yuko; Sakurai, Sayaka; Yamada, Akira; Shichijo, Shigeki; Itoh, Kyogo; Akagi, Yoshito

Early phase II study of mixed 19-peptide vaccine monotherapy for refractory triple-negative breast cancer

针对难治性三阴性乳腺癌的混合19肽疫苗单药疗法的早期II期研究

期刊:Cancer Science

影响因子:4.3

doi:10.1111/cas.14510

Toh, Uhi; Sakurai, Sayaka; Saku, Shuko; Takao, Yuko; Okabe, Mina; Iwakuma, Nobutaka; Shichijo, Shigeki; Yamada, Akira; Itoh, Kyogo; Akagi, Yoshito

Predictive factors of the tumor immunological microenvironment for long-term follow-up in early stage breast cancer

早期乳腺癌肿瘤免疫微环境的长期随访预测因素

期刊:Cancer Science

影响因子:4.3

doi:10.1111/cas.13114

Okabe, Mina; Toh, Uhi; Iwakuma, Nobutaka; Saku, Shuko; Akashi, Momoko; Kimitsuki, Yuko; Seki, Naoko; Kawahara, Akihiko; Ogo, Etsuyo; Itoh, Kyogo; Akagi, Yoshito

Comprehensive genetic profiling using tissue and blood in locally advanced tumors.

利用组织和血液对局部晚期肿瘤进行全面的基因分析

Axillary surgery in patients with breast cancer with one to three positive micro- or macrometastases in the sentinel lymph nodes: an observational study

腋窝手术治疗前哨淋巴结中存在 1 至 3 个微转移或大转移的乳腺癌患者：一项观察性研究

Male Occult Primary Breast Cancer Diagnosed with Small Bowel Metastases: A Case Report

男性隐匿性原发性乳腺癌伴小肠转移：病例报告

The effective duration of systemic therapy and the neutrophil-to-lymphocyte ratio predict the surgical advantage of primary tumor resection in patients with de novo stage IV breast cancer: a retrospective study

系统治疗的有效持续时间和中性粒细胞与淋巴细胞比值可预测初诊IV期乳腺癌患者原发肿瘤切除术的手术优势：一项回顾性研究

Fulvestrant plus palbociclib in advanced or metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer after fulvestrant monotherapy: Japan Breast Cancer Research Group-M07 (FUTURE trial)

在接受氟维司群单药治疗后，晚期或转移性激素受体阳性/人表皮生长因子受体 2 阴性乳腺癌患者接受氟维司群联合帕博西尼治疗的疗效：日本乳腺癌研究组-M07（FUTURE 试验）

Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study

贝伐珠单抗联合紫杉醇作为局部晚期或转移性乳腺癌一线或二线化疗的前瞻性观察研究：JBCRG-C05 (B-SHARE) 研究

Clinical outcomes of patients after nipple-sparing mastectomy and reconstruction based on the expander/implant technique

保留乳头乳房切除术和基于扩张器/假体技术的重建术后患者的临床结果

Plasma level of prostate related-antigen peptide-reactive IgG is a prognostic factor of patients with breast cancer treated with personalized peptide vaccines

血浆中前列腺相关抗原肽反应性IgG水平是接受个性化肽疫苗治疗的乳腺癌患者的预后因素。

Early phase II study of mixed 19-peptide vaccine monotherapy for refractory triple-negative breast cancer

针对难治性三阴性乳腺癌的混合19肽疫苗单药疗法的早期II期研究

Predictive factors of the tumor immunological microenvironment for long-term follow-up in early stage breast cancer

早期乳腺癌肿瘤免疫微环境的长期随访预测因素